Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndrome

References

• Brunning RDOA, Germing U, Le Beau MM, et al. Myelodysplastic syndromes. In: Swedrlow SHCE, Harris NL, Jaffe ES, et al. editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC; 2008. p. 87–107.
   Google Scholar
• Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med. 2009;361:1872–1885.
   PubMed Web of Science ®Google Scholar
• Troy JD, Atallah E, Geyer JT, et al. Myelodysplastic syndromes in the United States: an update for clinicians. Ann Med. 2014;46:283–289.
   PubMed Web of Science ®Google Scholar
• Sole F, Luno E, Sanzo C, et al. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica. 2005;90:1168–1178.
   PubMedGoogle Scholar
• Heaney ML, Golde DW. Myelodysplasia. N Engl J Med. 1999;340:1649–1660.
   PubMed Web of Science ®Google Scholar
• Mufti GJ. Chromosomal deletions in the myelodysplastic syndrome. Leuk Res. 1992;16:35–41.
   PubMed Web of Science ®Google Scholar
• Tefferi A, Mesa RA, Schroeder G, et al. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia. Br J Haematol. 2001;113:763–771.
   PubMed Web of Science ®Google Scholar
• Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341:1051–1062.
   PubMed Web of Science ®Google Scholar
• Dewald GW, Wright PI. Chromosome abnormalities in the myeloproliferative disorders. Semin Oncol. 1995;22:341–354.
   PubMed Web of Science ®Google Scholar
• Diez-Martin JL, Graham DL, Petitt RM, et al. Chromosome studies in 104 patients with polycythemia vera. Mayo Clin Proc. 1991;66:287–299.
   PubMed Web of Science ®Google Scholar
• Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–2088.
   PubMed Web of Science ®Google Scholar
• Sole F, Espinet B, Sanz GF, et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Espanol de Citogenetica Hematologica. Br J Haematol. 2000;108:346–356.
   PubMed Web of Science ®Google Scholar
• Bernasconi P, Klersy C, Boni M, et al. World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. Br J Haematol. 2007;137:193–205.
   PubMed Web of Science ®Google Scholar
• Malcovati L, Germing U, Kuendgen A, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol. 2007;25:3503–3510.
   PubMed Web of Science ®Google Scholar
• Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120:2454–2465.
   PubMed Web of Science ®Google Scholar
• Schanz J, Tuchler H, Sole F, et al. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol. 2012;30:820–829.
   PubMed Web of Science ®Google Scholar
• Valent P, Horny HP, Bennett JM, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res. 2007;31:727–736.
   PubMed Web of Science ®Google Scholar
• Valent P, Horny HP. Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions. Eur J Clin Invest. 2009;39:548–553.
   PubMed Web of Science ®Google Scholar
• Platzbecker U, Santini V, Mufti GJ, et al. Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshop. Leuk Res. 2012;36:264–270.
   PubMedGoogle Scholar
• Della Porta MG, Travaglino E, Boveri E, et al. Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes. Leukemia. 2015;29:66–75.
   PubMed Web of Science ®Google Scholar
• Steensma DP. Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors. Curr Hematol Malig Rep. 2012;7:310–320.
   PubMed Web of Science ®Google Scholar
• Garcia-Manero G. Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol. 2014;89:97–108.
   PubMed Web of Science ®Google Scholar
• Paulsson K, Johansson B. Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes. Pathol Biol (Paris). 2007;55:37–48.
   PubMed Web of Science ®Google Scholar
• Huret J. +8 or trisomy 8. Atlas Genet Cytogenet Oncol Haematol. 2009;13:75–77.
   Google Scholar
• Saumell S, Florensa L, Luno E, et al. Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes. Br J Haematol. 2012;159:311–321.
   PubMed Web of Science ®Google Scholar
• Lepretre S, Buchonnet G, Stamatoullas A, et al. Chromosome abnormalities in peripheral T-cell lymphoma. Cancer Genet Cytogenet. 2000;117:71–79.
   PubMed Web of Science ®Google Scholar
• Ferti AD, Panani AD, Stamouli MI, et al. M-FISH in gastric lymphoma. Cancer Genet Cytogenet 2004;155:63–66.
   PubMedGoogle Scholar
• Jonveaux P, Daniel MT, Martel V, et al. Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosomal abnormalities associated with hepatosplenic T gamma/delta lymphoma. Leukemia 1996;10:1453–1455.
   PubMed Web of Science ®Google Scholar
• Kadam PR, Advani SH, Bhisey AN. Cytogenetic studies in Hodgkin’s disease. Indian J Med Res 1990;92:307–314.
   PubMed Web of Science ®Google Scholar
• Cerretini R, Noriega MF, Narbaitz M, et al. New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas. Eur J Haematol. 2006;76:284–293.
   PubMed Web of Science ®Google Scholar
• Jaffe ES HN, Stein H, Vardiman JW (editors). World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001.
   Google Scholar
• Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pieri SA, and Stein H (editors) World Health Organization classification of tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC; 2008.
   Google Scholar
• ISCN (2009): An international system for human cytogenetic nomenclature. Shaffer LGSM, Campbell LJ, editors. Basel, Switzerland: S Karger; 2009.
   Google Scholar
• Hussein K, Van Dyke DL, Tefferi A. Conventional cytogenetics in myelofibrosis: literature review and discussion. Eur J Haematol. 2009;82:329–338.
   PubMed Web of Science ®Google Scholar
• Wiktor A, Rybicki BA, Piao ZS, et al. Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosomes Cancer. 2000;27:11–16.
   PubMed Web of Science ®Google Scholar
• Ma Y, Wang X, Xu X, et al. Prognostic value of trisomy 8 in primary myelodysplastic syndrome. Intern Med J. 2010;40:697–703.
   PubMed Web of Science ®Google Scholar
• Soupir CP, Vergilio JA, Kelly E, et al. Identification of del(20q) in a subset of patients diagnosed with idiopathic thrombocytopenic purpura. Br J Haematol. 2009;144:800–802.
   PubMed Web of Science ®Google Scholar
• Pavlu J, Emmerson J, Marks AJ, et al. Idiopathic cytopenia of undetermined significance and the minimal criteria for a diagnosis of myelodysplastic syndrome. Leuk Lymphoma. 2011;52:515–516.
   PubMed Web of Science ®Google Scholar
• Saitoh K, Miura I, Takahashi N, et al. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes. Blood. 1998;92:2886–2892.
   PubMed Web of Science ®Google Scholar
• Miura I, Takahashi N, Kobayashi Y, et al. Molecular cytogenetics of stem cells: target cells of chromosome aberrations as revealed by the application of fluorescence in situ hybridization to fluorescence-activated cell sorting. Int J Hematol. 2000;72:310–317.
   PubMed Web of Science ®Google Scholar
• Abruzzese E, Buss D, Rainer R, et al. Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukemia: a case report and cell lineage study. Ann Hematol. 1996;73:35–38.
   PubMed Web of Science ®Google Scholar
• Mishima A, Aoba M, Yamaji S, et al. Progression of a myelodysplastic syndrome with trisomy 8 to acute lymphoblastic leukemia. Am J Hematol. 1998;58:342
   PubMed Web of Science ®Google Scholar
• Kimura S, Kuroda J, Akaogi T, et al. Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis-Behçet’s syndrome. Leuk Lymphoma. 2001;42:115–121.
   PubMed Web of Science ®Google Scholar
• Chen HC, Chiu YM. Large-vessel thrombosis in intestinal Behçet’s disease complicated with myelodysplastic syndrome and trisomy 8. World J Gastroenterol. 2012;18:1137–1140.
   PubMed Web of Science ®Google Scholar
• Ripperger T, Tauscher M, Praulich I, et al. Constitutional trisomy 8p11.21-q11.21 mosaicism: a germline alteration predisposing to myeloid leukaemia. Br J Haematol. 2011;155:209–217.
   PubMed Web of Science ®Google Scholar
• Baidas S, Chen TJ, Kolev V, et al. Constitutional trisomy 8 mosaicism due to meiosis II non-disjunction in a phenotypically normal woman with hematologic abnormalities. Am J Med Genet. 2004;124A:383–387.
   PubMed Web of Science ®Google Scholar
• Becker H, Maharry K, Mrozek K, et al. Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8. Leukemia. 2014;28:1754–1758.
   PubMed Web of Science ®Google Scholar
• Kwok B, Hall JM, Witte JS, et al. MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance. Blood. 2015;126:2355–2361.
   PubMed Web of Science ®Google Scholar